CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Dietary Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02708108
NCT02708108N/ACompleted

Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)

Children's Hospital Los Angeles·interventional·Posted Mar 15, 2016·Updated Mar 28, 2023

In Brief

A clinical study evaluating Dietary Intervention and Activity and Exercise Intervention for B Precursor Type Acute Leukemia. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This study tests the ability of a focused dietary, exercise, and activity intervention to reduce fat gain during induction therapy for childhood acute lymphoblastic leukemia to improve disease response and reduce toxicity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 15, 2016
Enrollment StartMay 1, 2016
Primary CompletionApr 1, 2019
Study CompletionDec 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.3 years ago

Interventions

Dietary Interventionbehavioral

Beginning at time of diagnosis, the dietary component of the intervention uses a personalized menu to implement high protein, moderate fat, and low glycemic index/high fiber diet to achieve a minimum net -10% daily caloric deficit during the induction phase of chemotherapy.

Activity and Exercise Interventionbehavioral

Beginning at the time of diagnosis, the exercise and activity component uses an "activity menu" to implement a target level of 200 minutes per week of moderate exercise activity (as estimated by metabolic equivalents) during the induction phase of chemotherapy.